CytomX Therapeutics, Inc. 10-Q, 10-Q/A, 10-QT, and 10-QT/A reports

Location
151 Oyster Point Blvd., Suite 400, South San Francisco, CA
State of incorporation
Delaware
Fiscal year end
December 31
Data updated at
8/23/2024, 01:36 AM
Form type Sec Links Description Filing date Reporting date
10-Q Report | Data 10-Q Aug 8, 2024 Jun 30, 2024
10-Q Report | Data 10-Q May 8, 2024 Mar 31, 2024
10-Q Report | Data 10-Q Nov 7, 2023 Sep 30, 2023
10-Q Report | Data 10-Q Aug 8, 2023 Jun 30, 2023
10-Q Report | Data 10-Q May 9, 2023 Mar 31, 2023
10-Q Report | Data 10-Q Nov 8, 2022 Sep 30, 2022
10-Q Report | Data 10-Q Aug 4, 2022 Jun 30, 2022
10-Q Report | Data 10-Q May 5, 2022 Mar 31, 2022
10-Q Report | Data 10-Q Nov 4, 2021 Sep 30, 2021
10-Q Report | Data 10-Q Aug 5, 2021 Jun 30, 2021
10-Q Report | Data 10-Q - Q1/2021 May 6, 2021 Mar 31, 2021
10-Q Report | Data 10-Q Q3/2020 Nov 5, 2020 Sep 30, 2020
10-Q Report | Data 10-Q - Q2/2020 Aug 6, 2020 Jun 30, 2020
10-Q Report | Data 10-Q May 7, 2020 Mar 31, 2020
10-Q Report | Data 10-Q Q3-2019_093019 Nov 7, 2019 Sep 30, 2019
10-Q Report | Data 2019 10-Q Q2 Aug 7, 2019 Jun 30, 2019
10-Q Report | Data 10-Q May 9, 2019 Mar 31, 2019
10-Q Report | Data CTMX-2018-09-30-10-Q Nov 6, 2018 Sep 30, 2018
10-Q Report | Data 10-Q Aug 8, 2018 Jun 30, 2018
10-Q Report | Data 10-Q May 9, 2018 Mar 31, 2018
10-Q Report | Data 10-Q Nov 7, 2017 Sep 30, 2017
10-Q Report | Data 10-Q Aug 7, 2017 Jun 30, 2017
10-Q Report | Data 10-Q May 5, 2017 Mar 31, 2017
10-Q Report | Data 10-Q Nov 3, 2016 Sep 30, 2016
10-Q Report | Data 10-Q Aug 3, 2016 Jun 30, 2016
10-Q Report | Data 10-Q May 6, 2016 Mar 31, 2016
10-Q Report | Data 10-Q Nov 23, 2015 Sep 30, 2015